Seoul, South Korea

Seock Yong Kang

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Daegu Gyeongbuk Institute of Science and Technology, Korea Institute of Science and Technology. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seock Yong Kang. Retrieved from https://idiyas.com/inventor/seock-yong-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 18.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Seock Yong Kang**

Introduction

Seock Yong Kang, located in Seoul, South Korea, is a notable inventor with a significant contribution to the field of pharmaceutical innovations. He holds five patents that showcase his dedication to advancing medical treatments for metabolic and protein kinase-related diseases. His inventions reflect a deep understanding of biochemical processes and an ambition to improve health outcomes.

Latest Patents

Seock Yong Kang's recent patents highlight his innovative approach toward combating metabolic disorders. One of his notable inventions is a compound exhibiting enteropeptidase inhibitory activity, which presents a novel solution for preventing and treating metabolic diseases such as obesity, diabetes mellitus, and hyperlipidemia. This compound operates primarily in the gastrointestinal tract, minimizing unwanted side effects while effectively promoting excretion instead of absorption.

Another significant invention is his pyrrolo-pyrimidine derivative compound, aimed at preventing or treating protein kinase-related diseases. This compound has shown promising inhibitory activity against LRRK2 kinase and various other protein kinases. It serves as a valuable addition to therapeutic strategies targeting conditions linked to protein kinase dysfunction, especially in the context of brain tumors.

Career Highlights

Seock Yong Kang's career is marked by his work with esteemed organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His tenure at these institutions emphasizes his commitment to research and development in medical biotechnology.

Collaborations

Throughout his career, Seock Yong Kang has collaborated with notable colleagues, including Hwan Geun Choi and Jung Beom Son. These partnerships have likely fostered an environment of innovation and expertise, further enhancing the quality and impact of his inventions.

Conclusion

Seock Yong Kang exemplifies the spirit of innovation within the pharmaceutical field. His patents not only provide potential therapeutic solutions but also reflect ongoing advancements in understanding and treating complex medical disorders. His work continues to inspire future innovations and contributes meaningfully to the landscape of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…